Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(618/week)
Manufacturing
(440/week)
Energy
(341/week)
Technology
(486/week)
Other Manufacturing
(364/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Immune checkpoint
Nov 04, 2019
Compugen Announces FDA Clearance of IND Application for COM902
Oct 26, 2019
Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences
Oct 09, 2019
iOmx Therapeutics Strengthens Executive Management Team and Supervisory Board
Sep 30, 2019
Medicenna Presented Promising Preclinical Results from its IL-2 Superkine Platform at the 5th Annual International Cancer Immunotherapy Conference
Sep 05, 2019
New Study Reinforces Clinical Utility of Combining Tumor Mutation Burden and PD-L1 as Predictive Biomarkers for Immune Checkpoint Inhibitor Therapy
Sep 05, 2019
CASI Pharmaceuticals, Inc. to Host Key Opinion Leader Symposium on September 10, 2019 in New York City
Sep 03, 2019
Inhibrx Reports Phase 1 Dose Escalation Results of INBRX-109, a Multivalent Agonist of Death Receptor 5
Aug 15, 2019
Mirati Therapeutics Appoints Jenny Gizzi As Vice President, Human Resources
Aug 08, 2019
Agenus Reports Second Quarter 2019 Financial Results and Provides Corporate Update
Aug 07, 2019
Regen BioPharma Inc. Files Immuno-Oncology Patent Application on Synergy of Cannabidiol With NR2F6 Modulation
Aug 05, 2019
Mirati Therapeutics Reports Second Quarter 2019 Financial Results
Aug 01, 2019
ImCheck Therapeutics Awarded EUR2 Million From Bpifrance to Advance its First-in-class Immunotherapy Program Into the Clinic
Jul 31, 2019
Medicenna Selects its Lead Immuno-Oncology Clinical Candidate, MDNA19, from its IL-2 Superkine Platform
Jun 20, 2019
Syntrix Pharmaceuticals Announces Dosing of First Patient in Phase 1/2 Clinical Trial of SX-682 in Combination with KEYTRUDA® (pembrolizumab) in Metastatic Melanoma
Jun 19, 2019
Nouscom Demonstrates Preclinical Proof of Concept for Personalized Cancer Neoantigen Vaccine in Combination With Immune Checkpoint Blockade to Eradicate Large Tumors
May 14, 2019
IMMUNE 3D® Expands Platform into New Disease Areas and Enters into Drug Discovery
May 07, 2019
BioLineRx Announces FDA Approval of IND Application for AGI-134, a Novel Immunotherapy Anti-Cancer Vaccine for Solid Tumors
Apr 29, 2019
Mirati Therapeutics Reports First Quarter 2019 Financial Results
Apr 10, 2019
Both Nobel Prize Winner and World-Leading Clinician Join Dragonfly Therapeutics' Scientific Leadership Team
Apr 08, 2019
Researchers Report SX-682 Could Enhance Multiple Forms of T Cell-Based Immunotherapies in Solid Tumors
‹‹
Page 3
››
Latest News
May 4, 2024
Berkshire Hathaway Inc. First Quarter 2024 Earnings Release
May 4, 2024
How to Prevent Heatstroke at Your Business with Airrex and PortaCool.
May 4, 2024
Kolibri Global Energy Inc. Revocation of Management Cease Trade Order
May 4, 2024
Anaergia Announces Additional Delay in the Filing of Its Audited Financial Statements and Related Disclosures
May 4, 2024
Electriq Power Holdings, Inc. Announces Chapter 7 Bankruptcy Filing
May 4, 2024
Atos: les créanciers et les banques ont fait une offre commune de refinancement
May 4, 2024
OSI Systems President and CEO Deepak Chopra to Retire by Calendar Year-End, Will Remain as Executive Chairman
May 4, 2024
Chesapeake Granite Wash Trust Announces Distribution of $0.0098 Per Common Unit
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events